Advances in Pharmacotherapy for Congenital Hyperinsulinism (nov, 10.1007/s40272-025-00727-0, 2025): Advances in Pharmacotherapy for Congenital Hyperinsulinism(Pediatric Drugs, 10.1007/s40272-025-00727-0)

In this article the statements “IB is involved with the patient charities Congenital Hyperinsulinism Charity, UK, and Congenital Hyperinsulinism International. PS is the founder of Congenital Hyperinsulinism India Association (CHIA), and is involved with the patient charities Congenital Hyperinsulinism Charity, UK (as Patron), and Congenital Hyperinsulinism International” in the Conflict of Interest section were incorrect but should have been “IB is involved with the patient charities Children’s Hyperinsulinism Charity, UK, and Congenital Hyperinsulinism International. PS is the founder of Congenital Hyperinsulinism India Association (CHIA), and is involved with the patient charities Children’s Hyperinsulinism Charity, UK (as Patron), and Congenital Hyperinsulinism International.” The original article has been corrected.